Publisher
Springer Science and Business Media LLC
Reference4 articles.
1. Reiter K, Hassler MR. Genetic testing and management of prostate cancer patients with pathogenic germline variants. memo. 2024;17((1). https://doi.org/10.1007/s12254-023):921–921.
2. Miszczyk M, Ślusarczyk A, Quhal F, Klemm J, Matsukawa A, Przydacz M, Bryniarski P, Shariat SF, Rajwa P. Management of oligometastatic prostate cancer. memo. 2024;17(1). https://doi.org/10.1007/s12254-023-00938-6.
3. Klemm J, Rajwa P, Miszczyk M, Brönimann S, Laukhtina E, Tsuboi I, Matsukawa A, Kardoust M, Karakiewicz PI, Shariat SF. Metastasis-directed therapy: new standard or too early to change paradigm? memo. 2024;17(1). https://doi.org/10.1007/s12254-023-00945-7.
4. Brönimann S, Singla N, Korn S, Hübner N, Shariat SF. Evidence and Emerging Trends in Local Therapy for Metastatic Hormone-Sensitive Prostate Cancer: A Narrative Review. memo. 2024; https://doi.org/10.1007/s12254-023-00934-w.